Discover how the combination of leflunomide and benazepril shows promise in protecting kidneys from diabetic nephropathy by targeting key molecular pathways.
Explore how Rosiglitazone protects kidney cells from AGEs and high glucose-induced damage in NRK-49F and MES-13 cell lines.